These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 21268564)

  • 1. New anticoagulants--how do they work?
    Kozek S
    Acta Anaesthesiol Belg; 2010; 61(3):125. PubMed ID: 21268564
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulants: newer ones, mechanisms, and perioperative updates.
    Gayle JA; Kaye AD; Kaye AM; Shah R
    Anesthesiol Clin; 2010 Dec; 28(4):667-79. PubMed ID: 21074744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antiplatelet agents.
    Samama M
    Acta Anaesthesiol Belg; 2010; 61(3):127. PubMed ID: 21268565
    [No Abstract]   [Full Text] [Related]  

  • 4. Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities.
    Xin N; Li YJ; Li Y; Dai RJ; Meng WW; Chen Y; Schlappi M; Deng YL
    J Ethnopharmacol; 2011 May; 135(2):510-4. PubMed ID: 21463670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. II. Looking into the future of platelet transfusion in the presence of P2Y(12) inhibitors.
    Tanaka KA; Subramaniam K
    Br J Anaesth; 2014 May; 112(5):780-4. PubMed ID: 24589868
    [No Abstract]   [Full Text] [Related]  

  • 6. Ticagrelor for the treatment of arterial thrombosis.
    Gurbel PA; Kereiakes DJ; Tantry US
    Expert Opin Pharmacother; 2010 Sep; 11(13):2251-9. PubMed ID: 20707759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ticagrelor effectively and reversibly blocks murine platelet P2Y12-mediated thrombosis and demonstrates a requirement for sustained P2Y12 inhibition to prevent subsequent neointima.
    Patil SB; Jackman LE; Francis SE; Judge HM; Nylander S; Storey RF
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2385-91. PubMed ID: 21071697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New anticoagulants].
    Levi M; Peters RJ; Piek JJ; Büller HR
    Ned Tijdschr Geneeskd; 2003 May; 147(19):909-15. PubMed ID: 12768805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF; Newby LJ; Heptinstall S
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombotic treatment in acute coronary syndromes.
    Hoole SP; Saw J
    Minerva Med; 2010 Aug; 101(4):215-38. PubMed ID: 21030935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonists.
    Thalji RK; Aiyar N; Davenport EA; Erhardt JA; Kallal LA; Morrow DM; Senadhi S; Burns-Kurtis CL; Marino JP
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4104-7. PubMed ID: 20542694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the best dose of aspirin in association with P2Y12 antagonists?
    Cattaneo M
    Heart; 2011 Feb; 97(3):263-4; author reply 264. PubMed ID: 21189314
    [No Abstract]   [Full Text] [Related]  

  • 14. [Update on new antithrombotic treatments].
    Boehlen F; Tirefort-Dimitrova Y; de Moerloose P; Fontana P
    Rev Med Suisse; 2010 Jan; 6(232):109-12. PubMed ID: 20170027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic stenting in patients on P2Y12 receptor antagonists and direct oral anticoagulants: are current BSG/ESGE guidelines practical?
    Murugesan SV; Hendrickse MT
    Gut; 2017 Feb; 66(2):384. PubMed ID: 27030508
    [No Abstract]   [Full Text] [Related]  

  • 16. A laboratory method for parallel determination of platelet aggregation and thrombin generation.
    Köstenberger M; Gallistl S; Cvirn G; Muntean W
    Clin Lab; 2004; 50(1-2):41-8. PubMed ID: 15000219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anticoagulants and platelet aggregation inhibitors in urology].
    Verdy E
    Prog Urol; 1997 Apr; 7(2):326-32. PubMed ID: 9264780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Author response to letter: colonic stenting in patients on P2Y12 receptor antagonists and direct oral anticoagulants-are current BSG/ESGE guidelines practical?
    Veitch A; Dumonceau JM
    Gut; 2017 Mar; 66(3):560-561. PubMed ID: 27196593
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of N-(3-hydroxy-1,3,5,(10)estratrien-17 beta-yl)-3-hydroxypropyl-amine (prolame) and estradiol-17 beta on platelet aggregation.
    Baños G; De la Peña A; Izaguirre RR; Mandoki JJ; Mendoza-Patiño N; Rubio-Póo C; Fernández JM
    Proc West Pharmacol Soc; 1991; 34():79-83. PubMed ID: 1788347
    [No Abstract]   [Full Text] [Related]  

  • 20. [From fibrinogen and hirudin to synthetic anticoagulants. Rational design of thrombin inhibitors].
    Steinmetzer T; Stürzebecher J
    Pharm Unserer Zeit; 2004; 33(3):196-205. PubMed ID: 15208908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.